Tempus AI (NASDAQ:TEM) Downgraded to “Neutral” at Bank of America

Tempus AI (NASDAQ:TEM) was downgraded by equities researchers at Bank of America from a “buy” rating to a “neutral” rating in a report issued on Wednesday, MarketBeat Ratings reports. They presently have a $60.00 target price on the stock, up from their prior target price of $45.00. Bank of America‘s price target points to a potential upside of 13.06% from the company’s current price.

TEM has been the topic of a number of other research reports. Piper Sandler initiated coverage on Tempus AI in a report on Monday, August 12th. They issued a “neutral” rating and a $40.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $45.00 price objective for the company. Morgan Stanley initiated coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective for the company. Loop Capital assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $48.00 price objective on the stock. Finally, TD Cowen began coverage on Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $50.00 target price for the company. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $47.67.

Tempus AI Price Performance

Shares of TEM stock opened at $53.07 on Wednesday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $77.00. The stock’s fifty day moving average price is $49.90.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, sell-side analysts anticipate that Tempus AI will post -6.51 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

Institutional investors and hedge funds have recently made changes to their positions in the company. Sandia Investment Management LP acquired a new stake in Tempus AI in the second quarter worth $136,000. Northwestern University bought a new stake in Tempus AI in the 2nd quarter valued at about $491,000. Squarepoint Ops LLC acquired a new stake in shares of Tempus AI in the second quarter valued at approximately $633,000. WINTON GROUP Ltd bought a new stake in shares of Tempus AI during the second quarter valued at approximately $634,000. Finally, Scientech Research LLC bought a new stake in shares of Tempus AI during the second quarter valued at approximately $756,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.